The apoptotic and transcriptional transactivation activities of p53 can be dissociated

Biochemistry and Cell Biology

Volumn 75, Issue 4, 1997, Pages 351-358

  Bissonnette, N ^a   Wasylyk, B ^b   Hunting, D J ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Apoptosis; DNA damage; p21 WAF1 CIP1; p53; Proteolytic cleavage; RNA polymerase II inhibition

Indexed keywords

CDKN1A PROTEIN, HUMAN; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEPTIDE HYDROLASE; PROTEIN P53; RNA POLYMERASE II;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CULTURE MEDIUM; DNA DAMAGE; DRUG ANTAGONISM; FIBROBLAST; GAMMA RADIATION; HUMAN; HYDROLYSIS; METABOLISM; MOUSE; MOUSE MUTANT; MUTATION; RADIATION EXPOSURE; TRANSACTIVATION; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; CELL LINE, TRANSFORMED; CULTURE MEDIA, SERUM-FREE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; FIBROBLASTS; GAMMA RAYS; HUMANS; HYDROLYSIS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MUTATION; PEPTIDE HYDROLASES; POLY(ADP-RIBOSE) POLYMERASES; RNA POLYMERASE II; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0031303868     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o97-058     Document Type: Article

References (13)

1. Abarzúa, P., LoSardo, J.E., Gubler, M.L., Sapathis, R., Lu, Y.-A., Felix, A., and Neri, A. 1996. Restoration of the transcription activation function to mutant p53 in human cancer cells. Oncogene, 13: 2477-2482.
2. WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine. Cell Growth Differ. 7: 893-901.
3. An, B., and Dou, Q.P. 1996. Cleavage of retinoblastoma protein during apoptosis: an interleukin 1-β-converting enzyme-like protease as candidate. Cancer Res. 56: 438-442.
4. Attardi, L.D., Lowe, S.W., Brugarolas, J., and Jacks, T. 1996. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15: 3693-3701.
5. Bakalkin, G., Yakovleva, T., Selivanova, G. Magnusson, K.P., Szekely, L., Kiseleva, E., Klein, G., Terenius, L., and Wiman, K.G. 1994. P53 binds single-stranded DNA ends and catalyses DNA renaturation and strand transfer. Proc. Natl. Acad. Sci. U.S.A. 91: 413-417.
6. Brugarolas, J., Chandrasekaran, C., Gordon, J.I., Beach, D., Jacks, T., and Hannon, G.J. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (London), 377: 552-557.
7. Gaelles, C., Helmberg, A., and Karin, M. 1994. P53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature (London), 370: 220-223.
8. Chen, X., Ko, L.J., Jayaraman, L., and Prives, C. 1996. P53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10: 2438-2451.
9. Clore, G.M., Ernst, J., Clubb, R., Omichinski, J.G., Poindexter Kennedy, W.M., Sakagushi, K., Appella, E., and Gronenborn, A.M. 1995. Refined solution structure of the oligomerisation domain of the tumour suppressor p53. Nat. Struct. Biol. 2: 321-333.
10. Deng, C., Zhang, P., Harper, J.W., Elledge, S.J., and Leder, P. 1995. Mice lacking p21/CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell, 82: 675-684.
11. Donahue, B.A., Yin, S., Taylor, J.S., Reines, D., and Hanawalt, P.C. 1994. Transcript cleavage by RNA polymerase II arrested by a cyclobutane pyrimidine dimer in the DNA template. Proc. Natl. Acad. Sci. U.S.A. 91: 8502-8506.
12. El-Deiry, W.S., Kern, S.E., Pietenpol, J.A., Kinzler, K.W., and Vogelstein, B. 1992. Definition of a consensus binding site for p53. Nat. Genet. 1: 45-19.
13. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825.